Published in N Engl J Med on October 11, 1990
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care (2011) 2.75
Glycated haemoglobin and metabolic control of diabetes mellitus: external versus locally established clinical targets for primary care. BMJ (1995) 2.35
Partial and incremental PCMH practice transformation: implications for quality and costs. Health Serv Res (2013) 1.58
Comparison of longitudinal point-of-care and high-performance liquid chromatography HbA1c measurements in a multi-centre trial. Diabet Med (2011) 1.45
Diabetes care in general practice: an approach to audit of process and outcome. Br J Gen Pract (1993) 1.40
Factors affecting outcome after total knee arthroplasty in patients with diabetes mellitus. Yonsei Med J (2008) 0.97
Are ancient proteins responsible for the age-related decline in health and fitness? Rejuvenation Res (2010) 0.87
What do Youth with Type 1 Diabetes Know about the HbA1c Test? Child Health Care (2010) 0.85
HbA1c: a review of analytical and clinical aspects. Ann Lab Med (2013) 0.84
Diabetes, glycemic control and risk of medical glaucoma treatment: A population-based case-control study. Clin Epidemiol (2009) 0.81
Diabetes and biomarkers. J Diabetes Sci Technol (2011) 0.80
Management of insulin-dependent diabetes mellitus. Drugs (1992) 0.77
Insulinization: A promising strategy for the treatment of type 2 diabetes mellitus. Exp Ther Med (2013) 0.76
Outpatient management of type 2 diabetic patients: a review of evidence-based literature. J Family Community Med (2006) 0.75
Fermentation of Green Tea with 2% Aquilariae lignum Increases the Anti-Diabetic Activity of Green Tea Aqueous Extracts in the High Fat-Fed Mouse. Nutrients (2015) 0.75
Knowledge of A1c Predicts Diabetes Self-Management and A1c Level among Chinese Patients with Type 2 Diabetes. PLoS One (2016) 0.75
Antichaperone activity and heme degradation effect of methyl tert-butyl ether (MTBE) on normal and diabetic hemoglobins. J Mol Recognit (2016) 0.75
A1C Testing and its Sociodemographic Predictors: Implications for Diabetes Self-management Programs. Health Serv Res Manag Epidemiol (2014) 0.75
Improving outcomes with POCT for HbA1c and blood ketone testing. J Diabetes Sci Technol (2007) 0.75
Glycaemic Control and Associated Self-Management Behaviours in Diabetic Outpatients: A Hospital Based Observation Study in Lusaka, Zambia. J Diabetes Res (2015) 0.75
Blood glycemia-modulating effects of melanian snail protein hydrolysates in mice with type II diabetes. Int J Mol Med (2017) 0.75
Hemoglobin Alc--infatuation or the real thing? N Engl J Med (1990) 0.75
Diagnostic value of cystatin C for diagnosis of early renal damages in type 2 diabetic mellitus patients: The first experience in Iran. J Res Med Sci (2015) 0.75
Glycosylation Gap in Patients with Diabetes with Chronic Kidney Disease and Healthy Participants: A Comparative Study. Indian J Endocrinol Metab (2017) 0.75
Randomised controlled trial of structured personal care of type 2 diabetes mellitus. BMJ (2001) 3.12
International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase (L-alanine: 2-oxoglutarate aminotransferase, EC 2.6.1.2). J Clin Chem Clin Biochem (1986) 1.51
Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients. J Am Coll Cardiol (1995) 1.36
International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 2. IFCC method for aspartate aminotransferase (L-aspartate: 2-oxoglutarate aminotransferase, EC 2.6.1.1). J Clin Chem Clin Biochem (1986) 1.26
The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain (1990) 1.20
An improved PCR-based method for site directed mutagenesis using megaprimers. Mol Cell Probes (1998) 1.19
Biochemical markers of ischaemia for the early identification of acute myocardial infarction without St segment elevation. Cardiology (2000) 1.06
Recommended method for the determination of creatine kinase in blood modified by the inclusion of EDTA. The Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology (SCE). Scand J Clin Lab Invest (1979) 1.06
Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction. Scand J Clin Lab Invest (1993) 1.02
Comparison of overnight, morning and 24-hour urine collections in the assessment of diabetic microalbuminuria. Diabet Med (1988) 1.02
International federation of clinical chemistry. Scientific committee. Expert panel on enzymes. IFCC document stage 2, draft 1; 1979-11-19 with a view to an IFCC recommendation. IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase. J Clin Chem Clin Biochem (1980) 1.00
The effect of treatment on obesity. A follow-up investigation of a material treated with complete starvation. Dan Med Bull (1970) 0.99
Mutations in endoglin and in activin receptor-like kinase 1 among Danish patients with hereditary haemorrhagic telangiectasia. Clin Genet (2004) 0.97
A comparison of analytical goals for haemoglobin A1c assays derived using different strategies. Ann Clin Biochem (1991) 0.93
Long-term variability in serum thyroglobulin and thyroid related hormones in healthy subjects. Acta Endocrinol (Copenh) (1980) 0.93
Effects of posture on concentrations of blood constituents in healthy adults: practical application of blood specimen collection procedures recommended by the Scandinavian Committee on Reference Values. Scand J Clin Lab Invest (1980) 0.93
31P-NMR measurements of ATP, ADP, 2,3-diphosphoglycerate and Mg2+ in human erythrocytes. Biochim Biophys Acta (1990) 0.92
Falsely negative urinary leucocyte counts due to delayed examination. Scand J Clin Lab Invest (1980) 0.92
The stability of blood, plasma and serum constituents during simulated transport. Scand J Clin Lab Invest (1981) 0.90
Elevated serum levels of creatine kinase BB in autosomal dominant osteopetrosis type II. Calcif Tissue Int (1991) 0.89
Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J (1994) 0.89
Reference intervals for trace elements in blood: significance of risk factors. Scand J Clin Lab Invest (1992) 0.87
Ultrarapid metabolism of sparteine: frequency of alleles with duplicated CYP2D6 genes in a Danish population as determined by restriction fragment length polymorphism and long polymerase chain reaction. Pharmacogenetics (1998) 0.86
Current trends in the collaboration of primary health care and clinical chemistry in the Nordic countries. Ups J Med Sci (1986) 0.85
Detection of a single base deletion in codon 424 of the low density lipoprotein receptor gene in a Danish family with familial hypercholesterolemia. Atherosclerosis (1994) 0.85
Vitamin D receptor alleles do not predict bone mineral density or bone loss in Danish perimenopausal women. Bone (1998) 0.85
Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population. Br J Clin Pharmacol (1999) 0.84
Analytical goals for the acceptance of common reference intervals for laboratories throughout a geographical area. Scand J Clin Lab Invest (1988) 0.84
Gene dosage and down-regulation of the alpha-interferon receptor. Scand J Clin Lab Invest (1992) 0.83
Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda. Hum Genet (2000) 0.83
Urinary iodine excretion in a geographically stratified Danish population sample not affected by iodination programmes. A change towards higher values. Acta Endocrinol (Copenh) (1988) 0.83
Gradation of unstable angina based on a sensitive immunoassay for serum creatine kinase MB. Br Heart J (1991) 0.83
Lymphocytic thyroiditis. I. correlation between morphological, immunological and clinical findings. Acta Med Scand (1977) 0.83
Risk stratification in suspected acute myocardial infarction based on a sensitive immunoassay for serum creatine kinase isoenzyme MB. A 2.5-year follow-up study in 156 consecutive patients. Cardiology (1992) 0.82
Clinically applicable mutation screening in familial hypercholesterolemia. Hum Mutat (1996) 0.81
Molecular genetic analysis of 1053 Danish individuals with clinical signs of familial hypercholesterolemia. Clin Genet (2006) 0.80
Evaluation of a clinically applicable mutation screening technique for genetic diagnosis of familial hypercholesterolemia and familial defective apolipoprotein B. Clin Genet (1998) 0.80
Variability of plasma proteins according to molecular size. Long-term and short-term intra-individual variation. Scand J Clin Lab Invest (1981) 0.80
31P NMR measurements of intracellular pH in erythrocytes: direct comparison with measurements using freeze-thaw and investigation into the influence of ionic strength and Mg2+. Magn Reson Med (1987) 0.80
A dual label oligonucleotide ligation assay for detection of the CYP2C19*1, CYP2C19*2, and CYP2C19*3 alleles involving time-resolved fluorometry. Ther Drug Monit (1998) 0.79
Analytical evaluation of a sensitive enzyme immunoassay for determinations of creatine kinase isoenzyme MB. Clin Chem (1990) 0.79
Creatine kinase and creatine kinase B-subunit in stable and unstable angina pectoris. Eur J Clin Invest (1986) 0.79
Serum lactate dehydrogenase isoenzyme 1 as a marker of testicular germ cell tumor. J Urol (1988) 0.79
Effects of posture on concentrations of serum proteins in healthy adults. Dependence on the molecular size of proteins. Scand J Clin Lab Invest (1980) 0.78
Assessment of the NMR visibility of intraerythrocytic sodium by flame photometric and ion-competitive studies. Magn Reson Med (1989) 0.78
[Laboratory medicine in primary health care--extent and costs]. Nord Med (1988) 0.78
The utility of glycated hemoglobin in identification of impaired glucose tolerance. Diabetes Res (1989) 0.78
Plasma enzymes in myocardial infarction. An appraisal of quantitative, clinical and pathophysiological information. Scand J Clin Lab Invest (1981) 0.78
Selenium status and the effect of organic and inorganic selenium supplementation in a group of elderly people in Denmark. Scand J Clin Lab Invest (1994) 0.78
Production and certification of an enzyme reference material for adenosine deaminase 1 (BCR 647). Clin Chim Acta (2001) 0.78
Expression and characterization of six clinically relevant uroporphyrinogen decarboxylase gene mutations. Scand J Clin Lab Invest (2005) 0.78
Diagnostic strategy, genetic diagnosis and identification of new mutations in intermittent porphyria by denaturing gradient gel electrophoresis. Hum Mutat (1997) 0.78
Phenotypic presentation of the FH-Cincinnati type 5 low density lipoprotein receptor mutation. Scand J Clin Lab Invest (1996) 0.78
Ways of assessing quality goals for diagnostic tests in clinical situations. Arch Pathol Lab Med (1988) 0.78
Calibration, specificity and trueness of a postheparin plasma lipoprotein lipase assay. Clin Chem Lab Med (2001) 0.77
Discrepancies in assessment of metabolic regulation in insulin-dependent diabetes mellitus--can we do without measurements of glycated haemoglobin? Diabetes Res (1990) 0.77
Reference values for six enzymes in plasma from newborns and women at delivery. Scand J Clin Lab Invest (1979) 0.77
Effect of increased gene dosage expression on the alpha-interferon receptors in Down's syndrome. Biochim Biophys Acta (1993) 0.77
Detection and characterization of a novel splice mutation in the LDL receptor intron 12 resulting in two different mutant mRNA variants. Atherosclerosis (1997) 0.77
Human ventricular myosin light chain isotype 1 as a marker of myocardial injury. Cardiology (1994) 0.77
Correlation between molecular genetic analyses and immunohistochemical evaluation of the epidermal growth factor receptor and p185HER2. Anticancer Res (1998) 0.77
The influence of analytical bias on diagnostic misclassifications. Clin Chim Acta (1997) 0.77
Fluoride, aluminum, and phosphate kinetics in cryolite workers. J Occup Med (1990) 0.77
Screening for haemochromatosis: prevalence among Danish blood donors. J Intern Med (1991) 0.77
Discrepancy in HbA1c measurements performed at different local laboratories and at a selected central reference laboratory. Ups J Med Sci (1993) 0.76
Characterization of two isoalleles and three mutations in both isoforms of purified recombinant human porphobilinogen deaminase. Scand J Clin Lab Invest (2005) 0.76
Quality specifications for haemoglobin A1c assays in the monitoring of diabetes. Ups J Med Sci (1993) 0.76
Metabolic evaluation of non-insulin-dependent diabetes in primary health care--the clinical usefulness of glycated haemoglobin measurements. Scand J Prim Health Care (1989) 0.76
Analytical goals for the estimation of non-Gaussian reference intervals. Scand J Clin Lab Invest (1989) 0.76
[Randomized controlled trial of structured, individualized treatment of type 2 diabetes mellitus. The project of Diabetes Care in General Practice]. Ugeskr Laeger (2001) 0.76
Increased IFN-alpha-induced sensitivity but reduced reactivity of 2',5'-oligoadenylate synthetase (2,5AS) in trisomy 21 blood lymphocytes. Clin Exp Immunol (1993) 0.76
A fast and robust dual-label nonradioactive oligonucleotide ligation assay for detection of factor V Leiden. Thromb Haemost (1997) 0.76
Transferability studies for the AACC reference method and the IFCC method for measurement of alkaline phosphatase activity. Clin Chem (1984) 0.75
The epidemiology of thyrotoxicosis in Denmark. Incidence and geographical variation in the Funen region 1972-1974. Acta Med Scand (1980) 0.75
Limitation of enzymatic models for predicting myocardial infarct size. Br Heart J (1983) 0.75
[Clinical needs for standardization of HbA1C]. Ugeskr Laeger (1994) 0.75
[Molecular effects of vitamin D on cell cycle and oncogenesis]. Ugeskr Laeger (1998) 0.75
Lymphocytic thyroiditis. II. The course of the disease in relation to morphologic, immunologic and clinical findings at the time of biopsy. Acta Med Scand (1977) 0.75
Denaturing gradient gel electrophoresis analysis of the hemochromatosis (HFE) gene: impact of HFE gene mutations on the manifestation of porphyria cutanea tarda. Clin Chem (1999) 0.75
Mutation screening by denaturing gradient gel electrophoresis in North American patients with acute intermittent porphyria. Clin Chem (1998) 0.75
[Assessment of medical technology in practice]. Ugeskr Laeger (1998) 0.75
Production and certification of an enzyme reference material for creatine kinase isoenzyme 2 (CRM 608). Clin Chim Acta (1998) 0.75
Clinical comparison between glibornuride (Glutril) and glibenclamide in maturity-onset diabetes: a controlled double-blind trial. Curr Ther Res Clin Exp (1976) 0.75
R325X mutation in exon 15 of the hydroxymethylbilane synthase gene identified in two Danish families with acute intermittent porphyria. Clin Chem (1996) 0.75
Mutation screening of the entire coding region of the protoporphyrinogen oxidase gene using denaturing gradient gel electrophoresis and denaturing hplc. Clin Chem (2001) 0.75
[Critical balance between the two cultures in medical education]. Ugeskr Laeger (2000) 0.75
[Medical graduates from the Odense University 1972-1998. Recruitment and employment]. Ugeskr Laeger (2000) 0.75
Certification of the mass concentration of creatine kinase isoenzyme 2 (CK-MB) in the reference material BCR 608. Clin Chem Lab Med (2001) 0.75
[DNA biobanks. Establishment and maintenance]. Ugeskr Laeger (1998) 0.75
[Questions as evident key to knowledge: teaching medical students evidence-based medicine]. Ugeskr Laeger (2001) 0.75
[It's about iron]. Ugeskr Laeger (1998) 0.75
[Clinical comparison between glibornuride (Glutril) and glibenclamide in senile diabetes. A controlled double-blind trial]. Ugeskr Laeger (1976) 0.75
[Cholestyramine therapy in type II hyperlipoproteinemia]. Ugeskr Laeger (1971) 0.75
[Clinics for counseling on cancer genetics. Experiences with genetic studies and counseling on familial breast cancer and colorectal cancer]. Ugeskr Laeger (1998) 0.75
[What is normal?]. Ugeskr Laeger (1997) 0.75
Lack of indication of myocardial cell damage after myocardial ischaemia in patients with severe stable angina. Eur Heart J (1992) 0.75